Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP692578.RAA1j2lr4ErGrVAhV6lDGpRUxrhXOxpoUVBb5x8RPfHVM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP692578.RAA1j2lr4ErGrVAhV6lDGpRUxrhXOxpoUVBb5x8RPfHVM130_assertion type Assertion NP692578.RAA1j2lr4ErGrVAhV6lDGpRUxrhXOxpoUVBb5x8RPfHVM130_head.
- NP692578.RAA1j2lr4ErGrVAhV6lDGpRUxrhXOxpoUVBb5x8RPfHVM130_assertion wasGeneratedBy ECO_0000203 NP692578.RAA1j2lr4ErGrVAhV6lDGpRUxrhXOxpoUVBb5x8RPfHVM130_provenance.
- NP692578.RAA1j2lr4ErGrVAhV6lDGpRUxrhXOxpoUVBb5x8RPfHVM130_assertion wasDerivedFrom befree-2016 NP692578.RAA1j2lr4ErGrVAhV6lDGpRUxrhXOxpoUVBb5x8RPfHVM130_provenance.
- NP692578.RAA1j2lr4ErGrVAhV6lDGpRUxrhXOxpoUVBb5x8RPfHVM130_assertion SIO_000772 18785805 NP692578.RAA1j2lr4ErGrVAhV6lDGpRUxrhXOxpoUVBb5x8RPfHVM130_provenance.
- NP692578.RAA1j2lr4ErGrVAhV6lDGpRUxrhXOxpoUVBb5x8RPfHVM130_assertion evidence source_evidence_literature NP692578.RAA1j2lr4ErGrVAhV6lDGpRUxrhXOxpoUVBb5x8RPfHVM130_provenance.
- NP692578.RAA1j2lr4ErGrVAhV6lDGpRUxrhXOxpoUVBb5x8RPfHVM130_assertion description "[Previstage GCC is a new diagnostic tool that may improve the accuracy of staging, prognosis of clinical outcomes and prediction of therapeutic responses to adjuvant therapy, representing a key advance in the management of patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692578.RAA1j2lr4ErGrVAhV6lDGpRUxrhXOxpoUVBb5x8RPfHVM130_provenance.